The Need for a Practical Approach to Evaluate the Effectiveness of COVID-19 Vaccines for Low- and Middle-Income Countries
Related Experiment Video
Updated: Oct 28, 2025
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Sabin Nsanzimana1, Alind Gupta2, Jean Paul Uwizihiwe1
11Rwanda Biomedical Centre, Kigali, Rwanda.
Insights
Evaluating COVID-19 vaccine effectiveness in low-income countries is crucial. Target trial emulation offers a practical, cost-effective method to assess real-world vaccine performance using observational data.
Area of Science:
- Epidemiology
- Vaccinology
- Public Health
Background:
- Global COVID-19 vaccine supply and manufacturing capacity are outpaced by demand, creating access challenges for low- and middle-income countries, especially in Africa.
- Clinical trials for COVID-19 vaccines have been limited in Africa, with few randomized clinical trials (RCTs) conducted.
- Monitoring real-world COVID-19 vaccine effectiveness in these regions is essential to address rollout inequities.
Purpose of the Study:
- To propose a practical and cost-effective method for evaluating the real-world effectiveness of COVID-19 vaccines in low- and middle-income countries.
- To address the limitations of conducting RCTs during mass vaccination campaigns.
- To highlight the utility of target trial emulation for assessing vaccine effectiveness in diverse populations.
Main Methods:
- Discusses target trial emulation, a method applying RCT design principles to observational data analysis.
- Addresses key considerations in observational data analysis, including uncontrolled confounders and selection biases.
- Emphasizes the framework's ability to improve the analysis of real-world data.
Main Results:
- Target trial emulation provides a feasible approach to monitor COVID-19 vaccine effectiveness during mass distribution.
- This method can overcome the practical challenges of conducting traditional RCTs in real-world settings.
- The framework enhances the reliability of observational data for vaccine effectiveness studies.
Conclusions:
- Target trial emulation is a valuable tool for evaluating COVID-19 vaccine effectiveness in resource-limited settings.
- It offers a practical solution for monitoring vaccine performance and informing public health strategies.
- This approach supports equitable vaccine deployment and monitoring globally.
Abstract:
The global demand for coronavirus disease 2019 (COVID-19) vaccines currently far outweighs the available global supply and manufacturing capacity. As a result, securing doses of vaccines for low- and middle-income countries has been challenging, particularly for African countries. Clinical trial investigation for COVID-19 vaccines has been rare in Africa, with the only randomized clinical trials (RCTs) for COVID-19 vaccines having been conducted in South Africa. In addition to addressing the current inequities in the vaccine roll-out for low- and middle-income countries, there is a need to monitor the real-world effectiveness of COVID-19 vaccines in these regions. Although RCTs are the superior method for evaluating vaccine efficacy, the feasibility of conducting RCTs to monitor COVID-19 vaccine effectiveness during mass vaccine campaigns will likely be low. There is still a need to evaluate the effectiveness of mass COVID-19 vaccine distribution in a practical manner. We discuss how target trial emulation, the application of trial design principles from RCTs to the analysis of observational data, can be used as a practical, cost-effective way to evaluate real-world effectiveness for COVID-19 vaccines. There are several study design considerations that need to be made in the analyses of observational data, such as uncontrolled confounders and selection biases. Target trial emulation accounts for these considerations to improve the analyses of observational data. The framework of target trial emulation provides a practical way to monitor the effectiveness of mass vaccine campaigns for COVID-19 using observational data.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:26Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
01:13Bioequivalence studies: Biowaivers
01:28Antimicrobial Effectiveness
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:20Measurement of Bioavailability: Pharmacodynamic Methods